November 16, 2012
…of the Institute for Palliative Medicine at San Diego Hospice, a teaching affiliate of the UC San Diego School of Medicine, is this year’s American Cancer Society “Pathfinder in Palliative Care” honoree. The award – which recognizes individuals who have demonstrated innovation and ingenuity in their contributions to the advancement…
April 22, 2015
…research in hospice and palliative medicine. Under a new five-year agreement, Scripps will work with UC San Diego to provide outpatient and inpatient hospice care for UC San Diego patients, allowing UC San Diego physicians to better coordinate post-acute care for patients with chronic illness. The joint fellowship program is…
February 7, 2019
…works collaboratively with a palliative care team made up of physicians, nurses, psychiatrists and social workers to support patients and their loved ones as they navigate challenging health conditions. Kestenbaum was recently named a Sojourns Scholar by Cambia Health Foundation, and received a two-year $180,000 grant to conduct an innovative…
January 9, 2023
UC San Diego School of Medicine study shows cannabis-related emergency department visits among older adults are on the rise with high risk for adverse effects of cannabis use for ages 65 and older.
May 20, 2021
Researchers at University of California San Diego School of Medicine found that functional impairments among adults aged 50 and older are associated with a higher risk of medical cannabis use; and prescription opioid and tranquilizer/sedative use and misuse.
April 9, 2013
As part of a multicenter clinical trial, researchers at University of California, San Diego School of Medicine are evaluating Pexa-Vec (JX-594) to slow the progression of hepatocellular carcinoma (HCC) or liver cancer. Pexa-Vec is a genetically engineered virus that is used in the smallpox vaccine.
May 1, 2013
UC San Diego Health System is a recipient of the 2012 Outstanding Achievement Award from the American College of Surgeons’ Commission on Cancer. Seventy-nine cancer care programs—three in California—received this national award based on excellence in providing quality care to cancer patients.
March 17, 2016
…California Institute for Regenerative Medicine approved yesterday a $6.3 million grant to a research team from the University of California, San Diego School of Medicine and University of California, Davis to pursue a novel human embryonic stem cell-based therapy to rescue and restore neurons devastated by amyotrophic lateral sclerosis or…
February 5, 2019
To make it easier for patients to receive world-class cancer care, UC San Diego Health has added a new multidisciplinary cancer clinic in Hillcrest and expanded its infusion center for both oncology patients and others in need of infusion services.
April 1, 2019
Moores Cancer Center at UC San Diego Health treats the first patient treated for cancer with a human-induced pluripotent stem cell (iPSC)-derived cell therapy called FT500. Dan Kaufman collaborated with Fate Therapeutics to bring the iPSC-derived natural killer cell cancer immunotherapy to patients.
